Relationship of IgA anti-ß2 glycoprotein I (anti-ß2-GPI) to some clinical manifestations.
| Factor | IgA Anti-ß2-GPI Present | IgA Anti-ß2-GPI Absent | p | OR (95% CI) |
|---|---|---|---|---|
| Sjögren’s syndrome, % | 10.6 | 17.0 | 0.05 | 0.58 (0.34–1.00) |
| Dry eye, % | 15.0 | 23.9 | 0.01 | 0.56 (0.35–0.90) |
| Dry mouth, % | 9.4 | 15.5 | 0.06 | 0.56 (0.32–1.00) |
| SLICC/ACR Damage Index | ||||
| Pulmonary hypertension, % | 8.9 | 4.1 | 0.02 | 2.26 (1.15–4.56) |
| Pulmonary fibrosis, % | 12.0 | 6.8 | 0.04 | 1.89 (1.06–3.35) |
| Total pulmonary damage | 0.27 ± 0.61 | 0.16 ± 0.45 | 0.007 | |
SLICC/ACR: Systemic Lupus International Collaborating Clinics/American College of Rheumatology.